APO Research

APO RESEARCH · REPORT

RNA Transcriptome Profiling Test

Selected research

Market Structure

Global RNA Transcriptome Profiling Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global RNA Transcriptome Profiling Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for RNA Transcriptome Profiling Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for RNA Transcriptome Profiling Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for RNA Transcriptome Profiling Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for RNA Transcriptome Profiling Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of RNA Transcriptome Profiling Test include Thermo Fisher Scientific, Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Merck KGaA, Eurofins Scientific and Pacific Biosciences of California, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global RNA Transcriptome Profiling Test market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of RNA Transcriptome Profiling Test and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents RNA Transcriptome Profiling Test revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the RNA Transcriptome Profiling Test market size, projected growth trends, production technologies, key applications, and end-use industries.

RNA Transcriptome Profiling Test Segment by Company

Thermo Fisher Scientific, Inc.

Illumina, Inc.

Agilent Technologies, Inc.

QIAGEN N.V.

F. Hoffmann-La Roche AG

Bio-Rad Laboratories, Inc.

Merck KGaA

Eurofins Scientific

Pacific Biosciences of California, Inc.

Promega Corporation

10x Genomics

Twist Bioscience

Bruker Spatial Biology

RNA Transcriptome Profiling Test Segment by Type

Consumables

Instruments

Software

Services

RNA Transcriptome Profiling Test Segment by Application

Hospital Based Laboratories

Diagnostic Centers

Academic and Research Institutes

Contract research Organizations (CROs)

Others

RNA Transcriptome Profiling Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Transcriptome Profiling Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RNA Transcriptome Profiling Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Transcriptome Profiling Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of RNA Transcriptome Profiling Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global RNA Transcriptome Profiling Test industry.

Chapter 3: Detailed analysis of RNA Transcriptome Profiling Test companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, RNA Transcriptome Profiling Testrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global RNA Transcriptome Profiling Test Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Consumables Table 3. Key Players of Instruments Table 4. Key Players of Software Table 3. Key Players of Services Table 4. Global RNA Transcriptome Profiling Test Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Based Laboratories Table 6. Key Players of Diagnostic Centers Table 7. Key Players of Academic and Research Institutes Table 8. Key Players of Contract research Organizations (CROs) Table 9. Key Players of Others Table 10. Global RNA Transcriptome Profiling Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global RNA Transcriptome Profiling Test Market Size by Region (2021-2026) & (US$ Million) Table 12. Global RNA Transcriptome Profiling Test Market Share by Region (2021-2026) Table 13. Global RNA Transcriptome Profiling Test Market Size by Region (2027-2032) & (US$ Million) Table 14. Global RNA Transcriptome Profiling Test Market Share by Region (2027-2032) Table 15. RNA Transcriptome Profiling Test Industry Trends Table 16. RNA Transcriptome Profiling Test Industry Drivers Table 17. RNA Transcriptome Profiling Test Industry Opportunities and Challenges Table 18. RNA Transcriptome Profiling Test Industry Restraints Table 19. Global RNA Transcriptome Profiling Test Revenue by Company (US$ Million) & (2021-2026) Table 20. Global RNA Transcriptome Profiling Test Revenue Market Share by Company (2021-2026) Table 21. Global RNA Transcriptome Profiling Test Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global RNA Transcriptome Profiling Test Key Company Head Office and Area Served Table 23. Global RNA Transcriptome Profiling Test Company, Product Type & Application Table 24. Global RNA Transcriptome Profiling Test Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global RNA Transcriptome Profiling Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global RNA Transcriptome Profiling Test Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global RNA Transcriptome Profiling Test Market Size by Type (2021-2026) & (US$ Million) Table 29. Global RNA Transcriptome Profiling Test Market Size by Type (2027-2032) & (US$ Million) Table 30. Global RNA Transcriptome Profiling Test Revenue Market Share by Type (2021-2026) Table 31. Global RNA Transcriptome Profiling Test Revenue Market Share by Type (2027-2032) Table 32. Global RNA Transcriptome Profiling Test Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global RNA Transcriptome Profiling Test Market Size by Application (2021-2026) & (US$ Million) Table 34. Global RNA Transcriptome Profiling Test Market Size by Application (2027-2032) & (US$ Million) Table 35. Global RNA Transcriptome Profiling Test Revenue Market Share by Application (2021-2026) Table 36. Global RNA Transcriptome Profiling Test Revenue Market Share by Application (2027-2032) Table 37. Thermo Fisher Scientific, Inc. Company Information Table 38. Thermo Fisher Scientific, Inc. Business Overview Table 39. Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 41. Thermo Fisher Scientific, Inc. Recent Development Table 42. Illumina, Inc. Company Information Table 43. Illumina, Inc. Business Overview Table 44. Illumina, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Illumina, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 46. Illumina, Inc. Recent Development Table 47. Agilent Technologies, Inc. Company Information Table 48. Agilent Technologies, Inc. Business Overview Table 49. Agilent Technologies, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Agilent Technologies, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 51. Agilent Technologies, Inc. Recent Development Table 52. QIAGEN N.V. Company Information Table 53. QIAGEN N.V. Business Overview Table 54. QIAGEN N.V. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. QIAGEN N.V. RNA Transcriptome Profiling Test Product Portfolio Table 56. QIAGEN N.V. Recent Development Table 57. F. Hoffmann-La Roche AG Company Information Table 58. F. Hoffmann-La Roche AG Business Overview Table 59. F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Product Portfolio Table 61. F. Hoffmann-La Roche AG Recent Development Table 62. Bio-Rad Laboratories, Inc. Company Information Table 63. Bio-Rad Laboratories, Inc. Business Overview Table 64. Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 66. Bio-Rad Laboratories, Inc. Recent Development Table 67. Merck KGaA Company Information Table 68. Merck KGaA Business Overview Table 69. Merck KGaA RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Merck KGaA RNA Transcriptome Profiling Test Product Portfolio Table 71. Merck KGaA Recent Development Table 72. Eurofins Scientific Company Information Table 73. Eurofins Scientific Business Overview Table 74. Eurofins Scientific RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Eurofins Scientific RNA Transcriptome Profiling Test Product Portfolio Table 76. Eurofins Scientific Recent Development Table 77. Pacific Biosciences of California, Inc. Company Information Table 78. Pacific Biosciences of California, Inc. Business Overview Table 79. Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 81. Pacific Biosciences of California, Inc. Recent Development Table 82. Promega Corporation Company Information Table 83. Promega Corporation Business Overview Table 84. Promega Corporation RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Promega Corporation RNA Transcriptome Profiling Test Product Portfolio Table 86. Promega Corporation Recent Development Table 87. 10x Genomics Company Information Table 88. 10x Genomics Business Overview Table 89. 10x Genomics RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. 10x Genomics RNA Transcriptome Profiling Test Product Portfolio Table 91. 10x Genomics Recent Development Table 92. Twist Bioscience Company Information Table 93. Twist Bioscience Business Overview Table 94. Twist Bioscience RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Twist Bioscience RNA Transcriptome Profiling Test Product Portfolio Table 96. Twist Bioscience Recent Development Table 97. Bruker Spatial Biology Company Information Table 98. Bruker Spatial Biology Business Overview Table 99. Bruker Spatial Biology RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Bruker Spatial Biology RNA Transcriptome Profiling Test Product Portfolio Table 101. Bruker Spatial Biology Recent Development Table 102. North America RNA Transcriptome Profiling Test Market Size by Type (2021-2026) & (US$ Million) Table 103. North America RNA Transcriptome Profiling Test Market Size by Type (2027-2032) & (US$ Million) Table 104. North America RNA Transcriptome Profiling Test Market Size by Application (2021-2026) & (US$ Million) Table 105. North America RNA Transcriptome Profiling Test Market Size by Application (2027-2032) & (US$ Million) Table 106. North America RNA Transcriptome Profiling Test Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America RNA Transcriptome Profiling Test Market Size by Country (2021-2026) Table 108. North America RNA Transcriptome Profiling Test Market Size by Country (2027-2032) Table 109. Europe RNA Transcriptome Profiling Test Market Size by Type (2021-2026) & (US$ Million) Table 110. Europe RNA Transcriptome Profiling Test Market Size by Type (2027-2032) & (US$ Million) Table 111. Europe RNA Transcriptome Profiling Test Market Size by Application (2021-2026) & (US$ Million) Table 112. Europe RNA Transcriptome Profiling Test Market Size by Application (2027-2032) & (US$ Million) Table 113. Europe RNA Transcriptome Profiling Test Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe RNA Transcriptome Profiling Test Market Size by Country (2021-2026) Table 115. Europe RNA Transcriptome Profiling Test Market Size by Country (2027-2032) Table 116. China RNA Transcriptome Profiling Test Market Size by Type (2021-2026) & (US$ Million) Table 117. China RNA Transcriptome Profiling Test Market Size by Type (2027-2032) & (US$ Million) Table 118. China RNA Transcriptome Profiling Test Market Size by Application (2021-2026) & (US$ Million) Table 119. China RNA Transcriptome Profiling Test Market Size by Application (2027-2032) & (US$ Million) Table 120. Asia RNA Transcriptome Profiling Test Market Size by Type (2021-2026) & (US$ Million) Table 121. Asia RNA Transcriptome Profiling Test Market Size by Type (2027-2032) & (US$ Million) Table 122. Asia RNA Transcriptome Profiling Test Market Size by Application (2021-2026) & (US$ Million) Table 123. Asia RNA Transcriptome Profiling Test Market Size by Application (2027-2032) & (US$ Million) Table 124. Asia RNA Transcriptome Profiling Test Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Asia RNA Transcriptome Profiling Test Market Size by Country (2021-2026) Table 126. Asia RNA Transcriptome Profiling Test Market Size by Country (2027-2032) Table 127. South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Type (2021-2026) & (US$ Million) Table 128. South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Type (2027-2032) & (US$ Million) Table 129. South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Application (2021-2026) & (US$ Million) Table 130. South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Application (2027-2032) & (US$ Million) Table 131. South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country (2021-2026) Table 133. South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country (2027-2032) Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. RNA Transcriptome Profiling Test Product Image Figure 2. Global RNA Transcriptome Profiling Test Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global RNA Transcriptome Profiling Test Market Share by Type: 2025 VS 2032 Figure 4. Consumables Image Figure 5. Instruments Image Figure 6. Software Image Figure 7. Services Image Figure 8. Global RNA Transcriptome Profiling Test Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global RNA Transcriptome Profiling Test Market Share by Application: 2025 VS 2032 Figure 10. Hospital Based Laboratories Image Figure 11. Diagnostic Centers Image Figure 12. Academic and Research Institutes Image Figure 13. Contract research Organizations (CROs) Image Figure 14. Others Image Figure 15. Global RNA Transcriptome Profiling Test Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 17. Global RNA Transcriptome Profiling Test Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global RNA Transcriptome Profiling Test Market Share by Players in 2025 Figure 20. Global Top 5 and 10 RNA Transcriptome Profiling Test Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global RNA Transcriptome Profiling Test Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global RNA Transcriptome Profiling Test Revenue Market Share by Type (2021-2032) Figure 24. Global RNA Transcriptome Profiling Test Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global RNA Transcriptome Profiling Test Revenue Market Share by Application (2021-2032) Figure 26. North America RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 27. North America RNA Transcriptome Profiling Test Market Share by Type (2021-2032) Figure 28. North America RNA Transcriptome Profiling Test Market Share by Application (2021-2032) Figure 29. North America RNA Transcriptome Profiling Test Market Share by Country (2021-2032) Figure 30. United States RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 31. Canada RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 32. Mexico RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 33. Europe RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 34. Europe RNA Transcriptome Profiling Test Market Share by Type (2021-2032) Figure 35. Europe RNA Transcriptome Profiling Test Market Share by Application (2021-2032) Figure 36. Europe RNA Transcriptome Profiling Test Market Share by Country (2021-2032) Figure 37. Germany RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 38. France RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 39. U.K. RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 40. Italy RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 41. Russia RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 43. China RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 44. China RNA Transcriptome Profiling Test Market Share by Type (2021-2032) Figure 45. China RNA Transcriptome Profiling Test Market Share by Application (2021-2032) Figure 46. Asia RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 47. Asia RNA Transcriptome Profiling Test Market Share by Type (2021-2032) Figure 48. Asia RNA Transcriptome Profiling Test Market Share by Application (2021-2032) Figure 49. Asia RNA Transcriptome Profiling Test Market Share by Country (2021-2032) Figure 50. Japan RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 51. South Korea RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 54. India RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 55. Australia RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa RNA Transcriptome Profiling Test Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa RNA Transcriptome Profiling Test Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa RNA Transcriptome Profiling Test Market Share by Country (2021-2032) Figure 60. Brazil RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 61. South Africa RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 63. Turkey RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 64. Argentina RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 65. UAE RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 66. Egypt RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 67. Chile RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Consumables
  • Instruments
  • Software
  • Services
Applications
  • Hospital Based Laboratories
  • Diagnostic Centers
  • Academic and Research Institutes
  • Contract research Organizations (CROs)
  • Others
Companies covered
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Eurofins Scientific
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • 10x Genomics
  • Twist Bioscience
  • Bruker Spatial Biology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global RNA Transcriptome Profiling Test Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Consumables
  5. 1.2.3 Instruments
  6. 1.2.4 Software
  7. 1.2.5 Services
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global RNA Transcriptome Profiling Test Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital Based Laboratories
  11. 1.3.3 Diagnostic Centers
  12. 1.3.4 Academic and Research Institutes
  13. 1.3.5 Contract research Organizations (CROs)
  14. 1.3.6 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global RNA Transcriptome Profiling Test Growth Trends by Region
  17. 1.5.1 Global RNA Transcriptome Profiling Test Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 RNA Transcriptome Profiling Test Market Size by Region (2021-2026)
  19. 1.5.3 RNA Transcriptome Profiling Test Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global RNA Transcriptome Profiling Test Market Dynamics
  1. 2.1 RNA Transcriptome Profiling Test Industry Trends
  2. 2.2 RNA Transcriptome Profiling Test Industry Drivers
  3. 2.3 RNA Transcriptome Profiling Test Industry Opportunities and Challenges
  4. 2.4 RNA Transcriptome Profiling Test Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global RNA Transcriptome Profiling Test Revenue by Company (2021-2026)
  2. 3.2 Global RNA Transcriptome Profiling Test Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global RNA Transcriptome Profiling Test Key Company Head office and Area Served
  4. 3.4 Global RNA Transcriptome Profiling Test Company, Product Type & Application
  5. 3.5 Global RNA Transcriptome Profiling Test Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global RNA Transcriptome Profiling Test Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 RNA Transcriptome Profiling Test Players Market Share by Revenue in 2025
  9. 3.6.3 2025 RNA Transcriptome Profiling Test Tier 1, Tier 2, and Tier 3
4 RNA Transcriptome Profiling Test Market by Type
  1. 4.1 Global RNA Transcriptome Profiling Test Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global RNA Transcriptome Profiling Test Market Size by Type (2021-2032)
  3. 4.3 Global RNA Transcriptome Profiling Test Market Size Share by Type (2021-2032)
5 RNA Transcriptome Profiling Test Market by Application
  1. 5.1 Global RNA Transcriptome Profiling Test Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global RNA Transcriptome Profiling Test Market Size by Application (2021-2032)
  3. 5.3 Global RNA Transcriptome Profiling Test Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific, Inc.
  2. 6.1.1 Thermo Fisher Scientific, Inc. Company Information
  3. 6.1.2 Thermo Fisher Scientific, Inc. Business Overview
  4. 6.1.3 Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific, Inc. Recent Developments
  7. 6.2 Illumina, Inc.
  8. 6.2.1 Illumina, Inc. Company Information
  9. 6.2.2 Illumina, Inc. Business Overview
  10. 6.2.3 Illumina, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Illumina, Inc. RNA Transcriptome Profiling Test Product Portfolio
  12. 6.2.5 Illumina, Inc. Recent Developments
  13. 6.3 Agilent Technologies, Inc.
  14. 6.3.1 Agilent Technologies, Inc. Company Information
  15. 6.3.2 Agilent Technologies, Inc. Business Overview
  16. 6.3.3 Agilent Technologies, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Agilent Technologies, Inc. RNA Transcriptome Profiling Test Product Portfolio
  18. 6.3.5 Agilent Technologies, Inc. Recent Developments
  19. 6.4 QIAGEN N.V.
  20. 6.4.1 QIAGEN N.V. Company Information
  21. 6.4.2 QIAGEN N.V. Business Overview
  22. 6.4.3 QIAGEN N.V. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 QIAGEN N.V. RNA Transcriptome Profiling Test Product Portfolio
  24. 6.4.5 QIAGEN N.V. Recent Developments
  25. 6.5 F. Hoffmann-La Roche AG
  26. 6.5.1 F. Hoffmann-La Roche AG Company Information
  27. 6.5.2 F. Hoffmann-La Roche AG Business Overview
  28. 6.5.3 F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Product Portfolio
  30. 6.5.5 F. Hoffmann-La Roche AG Recent Developments
  31. 6.6 Bio-Rad Laboratories, Inc.
  32. 6.6.1 Bio-Rad Laboratories, Inc. Company Information
  33. 6.6.2 Bio-Rad Laboratories, Inc. Business Overview
  34. 6.6.3 Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Product Portfolio
  36. 6.6.5 Bio-Rad Laboratories, Inc. Recent Developments
  37. 6.7 Merck KGaA
  38. 6.7.1 Merck KGaA Company Information
  39. 6.7.2 Merck KGaA Business Overview
  40. 6.7.3 Merck KGaA RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Merck KGaA RNA Transcriptome Profiling Test Product Portfolio
  42. 6.7.5 Merck KGaA Recent Developments
  43. 6.8 Eurofins Scientific
  44. 6.8.1 Eurofins Scientific Company Information
  45. 6.8.2 Eurofins Scientific Business Overview
  46. 6.8.3 Eurofins Scientific RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Eurofins Scientific RNA Transcriptome Profiling Test Product Portfolio
  48. 6.8.5 Eurofins Scientific Recent Developments
  49. 6.9 Pacific Biosciences of California, Inc.
  50. 6.9.1 Pacific Biosciences of California, Inc. Company Information
  51. 6.9.2 Pacific Biosciences of California, Inc. Business Overview
  52. 6.9.3 Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Product Portfolio
  54. 6.9.5 Pacific Biosciences of California, Inc. Recent Developments
  55. 6.10 Promega Corporation
  56. 6.10.1 Promega Corporation Company Information
  57. 6.10.2 Promega Corporation Business Overview
  58. 6.10.3 Promega Corporation RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Promega Corporation RNA Transcriptome Profiling Test Product Portfolio
  60. 6.10.5 Promega Corporation Recent Developments
  61. 6.11 10x Genomics
  62. 6.11.1 10x Genomics Company Information
  63. 6.11.2 10x Genomics Business Overview
  64. 6.11.3 10x Genomics RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 10x Genomics RNA Transcriptome Profiling Test Product Portfolio
  66. 6.11.5 10x Genomics Recent Developments
  67. 6.12 Twist Bioscience
  68. 6.12.1 Twist Bioscience Company Information
  69. 6.12.2 Twist Bioscience Business Overview
  70. 6.12.3 Twist Bioscience RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Twist Bioscience RNA Transcriptome Profiling Test Product Portfolio
  72. 6.12.5 Twist Bioscience Recent Developments
  73. 6.13 Bruker Spatial Biology
  74. 6.13.1 Bruker Spatial Biology Company Information
  75. 6.13.2 Bruker Spatial Biology Business Overview
  76. 6.13.3 Bruker Spatial Biology RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Bruker Spatial Biology RNA Transcriptome Profiling Test Product Portfolio
  78. 6.13.5 Bruker Spatial Biology Recent Developments
7 North America
  1. 7.1 North America RNA Transcriptome Profiling Test Market Size (2021-2032)
  2. 7.2 North America RNA Transcriptome Profiling Test Market Size by Type
  3. 7.2.1 North America RNA Transcriptome Profiling Test Market Size by Type (2021-2026)
  4. 7.2.2 North America RNA Transcriptome Profiling Test Market Size by Type (2027-2032)
  5. 7.2.3 North America RNA Transcriptome Profiling Test Market Share by Type (2021-2032)
  6. 7.3 North America RNA Transcriptome Profiling Test Market Size by Application
  7. 7.3.1 North America RNA Transcriptome Profiling Test Market Size by Application (2021-2026)
  8. 7.3.2 North America RNA Transcriptome Profiling Test Market Size by Application (2027-2032)
  9. 7.3.3 North America RNA Transcriptome Profiling Test Market Share by Application (2021-2032)
  10. 7.4 North America RNA Transcriptome Profiling Test Market Size by Country
  11. 7.4.1 North America RNA Transcriptome Profiling Test Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
  13. 7.4.3 North America RNA Transcriptome Profiling Test Market Size by Country (2027-2032)
  14. 7.4.4 North America RNA Transcriptome Profiling Test Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe RNA Transcriptome Profiling Test Market Size (2021-2032)
  2. 8.2 Europe RNA Transcriptome Profiling Test Market Size by Type
  3. 8.2.1 Europe RNA Transcriptome Profiling Test Market Size by Type (2021-2026)
  4. 8.2.2 Europe RNA Transcriptome Profiling Test Market Size by Type (2027-2032)
  5. 8.2.3 Europe RNA Transcriptome Profiling Test Market Share by Type (2021-2032)
  6. 8.3 Europe RNA Transcriptome Profiling Test Market Size by Application
  7. 8.3.1 Europe RNA Transcriptome Profiling Test Market Size by Application (2021-2026)
  8. 8.3.2 Europe RNA Transcriptome Profiling Test Market Size by Application (2027-2032)
  9. 8.3.3 Europe RNA Transcriptome Profiling Test Market Share by Application (2021-2032)
  10. 8.4 Europe RNA Transcriptome Profiling Test Market Size by Country
  11. 8.4.1 Europe RNA Transcriptome Profiling Test Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
  13. 8.4.3 Europe RNA Transcriptome Profiling Test Market Size by Country (2027-2032)
  14. 8.4.4 Europe RNA Transcriptome Profiling Test Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China RNA Transcriptome Profiling Test Market Size (2021-2032)
  2. 9.2 China RNA Transcriptome Profiling Test Market Size by Type
  3. 9.2.1 China RNA Transcriptome Profiling Test Market Size by Type (2021-2026)
  4. 9.2.2 China RNA Transcriptome Profiling Test Market Size by Type (2027-2032)
  5. 9.2.3 China RNA Transcriptome Profiling Test Market Share by Type (2021-2032)
  6. 9.3 China RNA Transcriptome Profiling Test Market Size by Application
  7. 9.3.1 China RNA Transcriptome Profiling Test Market Size by Application (2021-2026)
  8. 9.3.2 China RNA Transcriptome Profiling Test Market Size by Application (2027-2032)
  9. 9.3.3 China RNA Transcriptome Profiling Test Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia RNA Transcriptome Profiling Test Market Size (2021-2032)
  2. 10.2 Asia RNA Transcriptome Profiling Test Market Size by Type
  3. 10.2.1 Asia RNA Transcriptome Profiling Test Market Size by Type (2021-2026)
  4. 10.2.2 Asia RNA Transcriptome Profiling Test Market Size by Type (2027-2032)
  5. 10.2.3 Asia RNA Transcriptome Profiling Test Market Share by Type (2021-2032)
  6. 10.3 Asia RNA Transcriptome Profiling Test Market Size by Application
  7. 10.3.1 Asia RNA Transcriptome Profiling Test Market Size by Application (2021-2026)
  8. 10.3.2 Asia RNA Transcriptome Profiling Test Market Size by Application (2027-2032)
  9. 10.3.3 Asia RNA Transcriptome Profiling Test Market Share by Application (2021-2032)
  10. 10.4 Asia RNA Transcriptome Profiling Test Market Size by Country
  11. 10.4.1 Asia RNA Transcriptome Profiling Test Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
  13. 10.4.3 Asia RNA Transcriptome Profiling Test Market Size by Country (2027-2032)
  14. 10.4.4 Asia RNA Transcriptome Profiling Test Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Type
  3. 11.2.1 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Application
  7. 11.3.1 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country
  11. 11.4.1 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research